EDGAR Filing Documents for 0000917296-13-000002

Form D/A - Notice of Exempt Offering of Securities: [Amend]

SEC Accession No. 0000917296-13-000002

Filing Date

2013-11-08

Accepted

2013-11-08 16:40:38

Documents

Effectiveness Date

2013-11-08

Items

Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D/A
1		primary_doc.xml	D/A	8392
	Complete submission text file	0000917296-13-000002.txt		9590

Mailing Address C/O GROSVENOR CAPITAL MANAGEMENT 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611

Business Address ONE SANSOME ST 39TH FL. SAN FRANCISCO CA 94104 3125066500

BIOTECHNOLOGY VALUE FUND II LP (Filer) CIK: 0001102444 (see all company filings)